Two Sigma Investments
HZNP

Two Sigma Investments’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Two Sigma Investments’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-20,600
Closed -$2.26M – 5154
2021
Q3 		$2.26M Buy
20,600
+9,600
+87% +$997K 0.01% 1877
2021
Q2 		$1.03M Buy
+11,000
New +$1.01M ﹤0.01% 2454
2019
Q4 		– Sell
-9,900
Closed -$270K – 4184
2019
Q3 		$270K Buy
+9,900
New +$256K ﹤0.01% 3022
2016
Q2 		– Sell
-12,000
Closed -$199K – 3400
2016
Q1 		$199K Buy
+12,000
New +$210K ﹤0.01% 2595

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Two Sigma Investments's HZNP Position: Q4 2023 in Review

Two Sigma Investments sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 16,100 shares — an estimated $1.86M sold.

Two Sigma Investments first reported a position in HZNP in Q3 2013 and held it in 27 quarters. The position peaked at $34.7M in Q3 2020. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Two Sigma Investments reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Two Sigma Investments sold 16,100 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $1.86M.
  • Two Sigma Investments first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2013 and held it in 27 quarters.
  • Two Sigma Investments's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $34.7M in Q3 2020.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Two Sigma Investments's 13F filing for Q4 2023, filed 14 Feb 2024.